In India, under the National Tuberculosis Elimination Programme, the government provides free treatment for multidrug-resistant tuberculosis; however, many patients seek care elsewhere, which is costly. To determine those out-of-pocket expenses, we interviewed 40 presumptive patients and found that they spent more than their median annual income before registering for the government program.

中文翻译：

---

2016-2017 年印度推定耐多药结核病患者的预治疗自付费用。

在印度，根据国家结核病消除计划，政府为耐多药结核病提供免费治疗；然而，许多患者到别处寻求治疗，费用昂贵。为了确定这些自付费用，我们采访了 40 名推定患者，发现他们在注册政府计划之前的支出超过了年收入中位数。